Pharm.D Ink

Covid-19: Phase 1 of vaccine rollout plan will continue with Johnson & Johnson - Mkhize | News24 South Africa's vaccine rollout will commence with Johnson & Johnson after the Oxford/AstraZeneca vaccine was found to be less effective against the dominant Covid-19 501Y.V2 variant in the country.

Cancer therapy with no visitors is 'hardest thing'

15 million doses of Sputnik vaccine ready for South Africa, pharma company says As soon as it gets emergency approval from the local authorities, the vaccines could be sent to SA.